| First Author | Hou S | Year | 2023 |
| Journal | Leukemia | Volume | 37 |
| Issue | 8 | Pages | 1626-1637 |
| PubMed ID | 37393343 | Mgi Jnum | J:340365 |
| Mgi Id | MGI:7514488 | Doi | 10.1038/s41375-023-01953-6 |
| Citation | Hou S, et al. (2023) PHF6 maintains acute myeloid leukemia via regulating NF-kappaB signaling pathway. Leukemia 37(8):1626-1637 |
| abstractText | Acute myeloid leukemia (AML) is a major hematopoietic malignancy characterized by the accumulation of immature and abnormally differentiated myeloid cells in bone marrow. Here with in vivo and in vitro models, we demonstrate that the Plant homeodomain finger gene 6 (PHF6) plays an important role in apoptosis and proliferation in myeloid leukemia. Phf6 deficiency could delay the progression of RUNX1-ETO9a and MLL-AF9-induced AML in mice. PHF6 depletion inhibited the NF-kappaB signaling pathways by disrupting the PHF6-p50 complex and partially inhibiting the nuclear translocation of p50 to suppress the expression of BCL2. Treating PHF6 over-expressed myeloid leukemia cells with NF-kappaB inhibitor (BAY11-7082) significantly increased their apoptosis and decreased their proliferation. Taken together, in contrast to PHF6 as a tumor suppressor in T-ALL as reported, we found that PHF6 also plays a pro-oncogenic role in myeloid leukemia, and thus potentially to be a therapeutic target for treating myeloid leukemia patients. |
